Indian Journal of Urology Users online:472  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size


 
URO RADIOLOGY
Year : 2007  |  Volume : 23  |  Issue : 1  |  Page : 79-80
 

Primary hyperoxaluria and systemic oxalosis


Department of Urology, Christian Medical College, Vellore, Tamilnadu, India

Correspondence Address:
K Sriram
Department of Urology, Christian Medical College, Vellore, Tamilnadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0970-1591.30276

Rights and Permissions

 

How to cite this article:
Sriram K, Kekre NS, Gopalakrishnan G. Primary hyperoxaluria and systemic oxalosis. Indian J Urol 2007;23:79-80

How to cite this URL:
Sriram K, Kekre NS, Gopalakrishnan G. Primary hyperoxaluria and systemic oxalosis. Indian J Urol [serial online] 2007 [cited 2019 Jul 23];23:79-80. Available from: http://www.indianjurol.com/text.asp?2007/23/1/79/30276


Primary hyperoxaluria (PH) is an autosomal recessive disorder of glyoxylate metabolism, characterized by an excessive production and urinary excretion of oxalate and glyoxylate (PH Type1 or PH1) or oxalate and L-glycerate (PH Type2 or PH2).

The basic defect in PH1 is a functional defect of hepatic enzyme, alanine: glyoxylate amino transferase (AGT). On the other hand, PH2 is characterized by a deficiency of glyoxylate reductase/hydroxypyruvate reductase (GRHPR).[1]

The basic problems in primary hyperoxaluria are caused by low solubility of Calcium oxalate (CaOx), which is deposited in the kidney and the urinary tract as nephrocalcinosis or urolithiasis [Figure - 1]A, B. This leads to renal failure at which point, the increased production of oxalate is compounded by the failure to remove it from the body resulting in a very high corporeal oxalate load leading onto CaOx deposition all over the body. An international registry for hyperoxaluria is operational for these patients since 2004.[2]

Deposition of oxalate in various extra-renal tissues leading to a systemic involvement is named as systemic oxalosis.[3] Bone marrow is one of the major compartments of the insoluble oxalate pool [Figure - 2]A. The other organs involved include soft tissue, heart, nerves, joints, skin, retina and other visceral lesions [Figure - 2]B.

The renal abnormalities include nephrocalcinosis caused by intratubular deposition of oxalate crystals. Plain radiographs may demonstrate an increasing density of the kidneys. On ultrasonography, the cortical echogenicity is increased early in the course of the disease, but with the onset of medullary calcification, the entire kidney becomes echogenic and the cortico-medullary differentiation is lost.

Computed tomography scan can detect the medullary and cortical calcifications even before they are evident on plain radiographs. Computed tomography attenuation values as high as 500 Houndsfield units have been reported. A global calcification of both the cortex and the medulla is characteristic of oxalosis. Mottled or speckled nephrocalcinosis may also be seen with methoxy flurane anesthesia and ethylene glycol poisoning. Diffuse cortical nephrocalcinosis is also seen in paraneoplastic hypercalciuria, Alport's syndrome, Acquired immunodeficiency syndrome-associated infections such as cytomegalovirus, mycobacterium avium-intracellulare infections. Medullary nephrocalcinosis is associated with medullary sponge kidney, hyperparathyroidism and renal tubular acidosis.

Soft tissue calcification can also occur in progressive systemic sclerosis, parasitic infestations, calcifying cavernous hemangioma, heterotopic calcifications after burn injuries, in tumor calcinosis and in the Thibierge-Weissenbach syndrome.[4] Each of these conditions is very rare and only a very few anecdotal reports are available in the literature. Crystalluria and infrared spectroscopy are useful in the identification and quantitative analysis of the crystals. However, a definitive diagnosis requires an assessment of enzyme assays in the liver tissue, facilities for which are not available in our country. The purpose of this Uro-radiology report is to emphasize that a combination of hyperoxaluria with nephrocalcinosis, extensive soft tissue calcification and progressive renal failure is sufficient to establish the diagnosis of systemic oxalosis obviating the need for enzyme assays in liver biopsy.

 
   References Top

1.Danpure CJ. Molecular etiology of primary hyperoxaluria type 1: New directions for treatment. Am J Nephrol 2005;25:303-10.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Lieske JC, Monico CG, Holmes WS, Bergstralh EJ, Slezak JM, Rohlinger AL, et al . International registry for primary hyperoxaluria. Am J Nephrol 2005;25:290-6.  Back to cited text no. 2    
3.Day DL, Scheinman JI, Mahan J. Radiological aspects of primary hyperoxaluria. AJR Am J Roentgenol 1986;146:395-401.  Back to cited text no. 3  [PUBMED]  
4.Hussmann J, Russell RC, Kucan JO, Khardori R, Steinau HU. Soft-tissue calcifications: Differential diagnosis and therapeutic approaches. Ann Plast Surg 1995;34:138-47.  Back to cited text no. 4  [PUBMED]  


    Figures

  [Figure - 1], [Figure - 2]



 

Top
Print this article  Email this article
Previous article Next article

    

 
   Search
 
   Next article
   Previous article 
   Table of Contents
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (115 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References
    Article Figures

 Article Access Statistics
    Viewed3073    
    Printed94    
    Emailed0    
    PDF Downloaded197    
    Comments [Add]    

Recommend this journal

HEALTHWARE INDIA